His remarks include:
Well, I would say that Merck played by the rules from everything that I've seen.
Well, the way things were, many of us consult with the pharmaceutical industry, which I think is a very good thing. They need ideas and then the decision about what they do is really up to the person who is funding the study.
(Article changed on February 6, 2015 at 12:32)
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).